Articles tagged with Rna Structure
Scientists engineered an enzyme that selectively recognizes and repairs broken RNA, suggesting that molecular tools needed to preserve the RNA-based genetic code could be furnished by RNA alone. This discovery has implications for understanding the origins of life and developing new biotechnology applications.
Computer scientists have developed a new AI tool called RNAbpFlow that can map RNA structures with high accuracy, rivaling Google's AlphaFold 3. The method uses flow matching and can generate complete 3D structures from scratch, making it useful for drug discovery and targeting specific RNA folds.
Researchers have developed a new method to build programmable artificial organelles inside living cells using RNA, enabling customization of cellular compartments and tunable properties. This approach may lead to specialized biological functions for nanomedicine and gene engineering.
Researchers at Kyoto University have detailed the structure of Borna disease virus 1's nucleoprotein-RNA complex, revealing a distinct binding mode and incremental model of viral replication. The study provides a molecular framework for targeting viral RNA synthesis and assembly.
Researchers have identified a framework to characterize RNA structure-changing small molecule drugs, which could lead to the development of better treatments targeting RNA directly. The study found that molecules binding to RNA rarely affect its function, while those altering its structure have a bigger impact.
In a mouse study, researchers successfully used RNA micelles to shrink metastasized tumors in lungs by delivering chemotherapy drugs and an RNA molecule that blocks cancer survival. The treatment significantly reduced tumor growth and improved outcomes for mice with colorectal cancer lung metastasis.
Glycosylated RNAs on the cell surface form clusters with RNA binding proteins, regulating interactions with surrounding growth factors and controlling angiogenesis. The study found that altering the amount of RNA on the cell surface can modify intracellular signaling cascades through selective interaction with growth factors.
Researchers identify circulating extracellular vesicles produced in diseased kidneys as the culprit behind toxicity in the heart. The discovery could lead to the development of a blood test to identify patients at high risk for serious heart problems and novel treatments to prevent and treat heart failure.
A study from UMBC reveals a conserved RNA-protein interaction as a promising target for broad-spectrum enterovirus antivirals. The researchers found that a fusion protein called 3CD recruits proteins to assemble the replication complex, and targeting this interface could lead to universal drugs.
Researchers at UMass Amherst have developed a new tool, iConRNA, that provides an unrivaled look inside cells and can help solve the mystery of how devastating diseases develop. The tool resolves the balance of physical driving forces of phase separation and predicts how this balance is tuned under different cellular situations.
Researchers developed a novel RNA-based therapy using lipid nanoparticles to silence a gene causing ceramide buildup in the liver, reducing inflammation and scarring. The treatment shows promise for millions of patients worldwide and could eventually benefit those with heart disease, obesity, and diabetes.
Researchers discovered that disordered regions enhance specific RNA interactions in FUS protein-RNA complexes, revealing a breakthrough strategy for nucleic acid binding. The study suggests that intrinsically disordered regions actively contribute to the RNA-binding mechanism.
Researchers discovered that our bodies add sugars to RNA, shielding it from the immune system. This 'sugarcoating' prevents inflammation and helps clean up dead cells.
Researchers have identified hundreds of RNA regulatory switches in living cells that can be used to develop new treatments for diseases. The discovery, published in Nature Biotechnology, uses a novel method to map the complex structures of RNA molecules and uncover functional switches with high accuracy.
A team from Kyushu University has discovered that the smallest known protein-based tRNA-processing enzyme, HARP, forms a star-shaped complex to cut both ends of tRNA. This finding sheds light on how HARP processes the 5' leader sequence and reveals a new mechanism for RNA processing.
Researchers at Northwestern University propose a new approach to therapeutic development using structural precision in nanomedicine. By fine-tuning the interaction between nanomedicines and the human body, scientists can design interventions that are more effective, targeted, and beneficial for patients.
Research reveals DHX36 plays a crucial role in normal chromatin architecture and rRNA homeostasis during oocyte growth. DHX36 deficiency impairs meiotic maturation, post-fertilization embryonic development, and disrupts ribosome assembly.
A machine-learning algorithm named catGRANULE 2.0 ROBOT identifies molecular targets for further researches and therapies in neurodegenerative diseases. The algorithm analyzes protein-RNA interaction to predict potential harm and identify early pathological signals.
Researchers at Kyoto University have captured the first high-resolution structure of Ebola's nucleocapsid using single-particle cryo-electron microscopy. This visualization reveals sophisticated interactions between structural components, including VP24 and NP proteins, which govern virus assembly, RNA synthesis, and transport.
Researchers at Rice University have gained insights into ADAR1's molecular mechanisms, which could lead to improved treatments for cancer and autoimmune diseases. The study found that ADAR1's editing activity depends on RNA sequence, duplex length, and mismatches near the editing site.
NuFold, a computational solution developed by Purdue University researchers, uses machine learning techniques to predict the 3D structures of RNA from its sequence. This breakthrough has wide-ranging potential applications in understanding RNA mechanisms and drug development for diseases involving RNA.
Researchers discovered a novel mechanism of intercellular communication through mRNA transfer between stem cells, allowing for biologically significant effects such as cell fate conversion and pluripotent state maintenance.
A team of researchers has uncovered the three-dimensional structure of a ribozyme called SAMURI, which can chemically modify other RNA molecules and influence their function. The study's findings could provide new directions for the development of RNA-based therapeutics.
A pioneering AI model has been developed to understand the genetic 'language' of plants, allowing for precise predictions about RNA functions and identification of functional patterns. This breakthrough has significant implications for crop improvement and the next generation of AI-based gene design.
Researchers have shed new light on gene expression by visualizing ribosomes in unprecedented detail. The study reveals a molecular mechanism for mRNA delivery to the ribosome, advancing our understanding of gene expression at the molecular level.
Scientists have captured 3D snapshots of individual RNA nanoparticles in motion, showcasing the dynamic and intricate folding process. This breakthrough uses advanced electron microscopy to study RNA's flexibility, enabling new insights into its structure and potential applications in molecular medicine.
A team at Penn State developed an experimental pipeline called Cleavage High-Throughput Assay (CHiTA) that can test the activity of thousands of predicted twister ribozymes. The study identified approximately 94% of tested ribozymes as active, revealing their function can persist even with slight imperfections.
Researchers at Kumamoto University identified G-quadruplexes as a central role in promoting alpha-synuclein aggregation, leading to neurodegenerative diseases. Inhibiting G4 assembly may prevent the onset of synucleopathies and position it as a promising target for early intervention.
Researchers demonstrate the first cross-chiral exponential amplification of an RNA enzyme, potentially leading to the development of cross-chiral therapeutics and biotechnologies. The discovery suggests that a bioengineer can create a new form of biochemical evolution by using both left- and right-handed molecules.
A groundbreaking study reveals how TRMT10A deficiency disrupts protein synthesis, synaptic structure, and function in the brain, leading to impaired cognitive abilities. Researchers found a significant decrease in specific tRNA levels, particularly those essential for initiating protein synthesis.
A University of Barcelona team has described new biochemistry for RNA at low temperatures, revealing unexpected novel structures that emerge below 20°C. This phenomenon is believed to be universal and common to all RNA molecules, with implications for the biochemistry and biological functions of RNA.
Scientists at St. Jude Children's Research Hospital have elucidated the structural mechanism of URAT1, a protein linked to gout, using cryo-electron microscopy. The findings reveal how URAT1 transports urate and offer new insights for developing more effective treatments for gout.
Researchers at TUM discovered a mechanism that enables double-stranded RNA molecules to form and remain stable in the primordial soup. This discovery has significant implications for understanding the origin of life and could lead to breakthroughs in medicine, particularly in vaccine development.
Researchers at the University of Alabama at Birmingham have discovered that the protein SRSF1 can bind and unfold complex RNA Guanine-quadruplexes. This finding could provide new avenues for treating illnesses such as cancer, which is often linked to misfunctioning splicing processes.
Scientists at the University of Nottingham have created a powerful method to analyze RNA structures in unprecedented detail. By combining cryogenic OrbiSIMS with advanced computational modelling and automation, they can now determine RNA structures in a matter of days, significantly advancing the field of RNA structural biology.
Researchers have determined the molecular level function of free-forming structures in plant cells that help sense light and temperature, enabling plants to distinguish a range of different light intensities. The formation of these organelles is not random but is linked to specific locations within the cell, particularly near centromeres.
Researchers have developed a new method to sequence single-cell RNA structures, revealing biomarkers crucial for human development and disease. This approach identifies cell types based on RNA shape, offering new insights into cellular fate and potential treatments against RNA viruses.
Yiliang Ding's pioneering work on RNA structure and function has led to breakthroughs in plant virus treatment, increasing structural understanding of this crucial molecule. Her award-winning research has the potential to drive scientific innovation in agriculture and human health.
Researchers have discovered the atomic structure of an RNA replicase using cryogenic electron microscopy, shedding light on a primordial 'RNA world' that kick-started evolution. The study provides structural insight into an ancient RNA machine thought to reside at the origin of life.
Researchers at Arizona State University successfully demonstrated the use of MicroED to analyze a DNA crystal, overcoming limitations of X-ray crystallography. The technique, combined with cryo-FIB milling, enables work with smaller crystals, opening opportunities for understanding RNA structure and developing novel nanotechnologies.
A breakthrough treatment targeting bone marrow cancer cells destroyed 90% of multiple myeloma cells in laboratory tests and 60% in human tissue samples. Researchers developed lipid-based nanoparticles containing RNA molecules that silence the CKAP5 gene, inhibiting cancer cell division.
Researchers at WVU have developed a way to view synthetic DNA at the atomic level, enabling them to understand how to change its structure for enhanced scissor-like function. This breakthrough could lead to new technology for medical diagnoses and treatments, including potential therapies for diseases like retinal degeneration and cancer.
Researchers have successfully visualized the three-dimensional structure of human tRNA splicing endonuclease TSEN, a crucial enzyme in tRNA maturation. The study reveals how TSEN recognizes and excises introns from precursor tRNAs, shedding light on its role in neurodegenerative disorders like pontocerebellar hypoplasia.
Scientists at Aarhus University and Berkeley Laboratory developed a method called RNA origami to design artificial RNA nanostructures. The technique allowed for the discovery of rules and mechanisms for RNA folding that will make it possible to build more ideal RNA particles for use in RNA-based medicine.
BasePairPuzzle is a new DNA molecular model that accurately represents intermolecular interactions, including hydrogen bonds. Students can visualize and experience the sensation of molecules interacting with each other using this innovative 3D-printed model.
Researchers developed a new method to quantify the structure and quality of messenger RNA (mRNA) medicines using liquid chromatography, mass spectrometry, and software analysis. The platform can analyze all three key components of mRNA medicines simultaneously, providing unparalleled efficiency in checking for quality.
Scientists have developed a technique to detect RNA structures in live cells, shedding light on the role of G-quadruplexes in neurodegenerative diseases. The method uses fluorescent spectroscopy and resolves existing limitations in studying these structures in real-time.
Researchers identify vulnerable cell populations in the striatum, which contributes to loss of motor control and early mood disorders. Damage to striosomes may be responsible for mood disorders, while degeneration of matrix neurons likely contributes to motor decline.
A new reporter system called INSPECT allows for highly sensitive monitoring of both coding and non-coding RNA production, shedding light on cellular processes. This breakthrough tool modifies introns without altering completed RNA or proteins, offering a minimally invasive solution to study RNA regulation.
Researchers reveal the dynamic nature of RNA molecules, which can take on multiple shapes and regulate cellular processes. The 'RNA structurome' holds key to understanding disease mechanisms and developing new therapeutic strategies.
Scientists have identified long interspersed nuclear element-1 (L1) RNA as a promising new target for treating progeroid syndromes. Increased L1 RNA expression in cells from patients with these disorders led to deactivation of an enzyme, causing cell aging.
Researchers at Cleveland Clinic's FRIC found that cytoskeleton disruption is a key signal for the body to respond to viruses. This discovery has potential implications for developing new anti-viral vaccines and treatments.
A new study reveals that the emergence of a new gene called PGBD1 is linked to the evolution of a new structure in nerve cells. PGBD1 controls paraspeckles, tiny structures that act like traps for RNAs and proteins, and its regulation is crucial for nerve cell development.
The study reveals that environmental conditions cause RNA structures to change, affecting plant flowering times and potentially leading to more desirable traits. This technology can also be applied to human cells, enabling the design of RNA-based therapies for diseases like SARS-COV-2.
Researchers at UT Southwestern Medical Center have identified a critical mechanism in the replication of SARS-CoV-2, the virus that causes COVID-19. The NiRAN domain plays a crucial role in synthesizing the RNA cap, which is essential for viral replication.
Researchers discovered a novel mechanism by which non-coding 7S RNA regulates mitochondrial gene expression in human cells. The study found that 7S RNA inhibits transcription via mitochondrial RNA polymerase dimerization, shedding light on the molecular basis of this process.
Cornell researchers develop smaller gene-editing tool, IscB-ωRNA, to solve size problem of delivering CRISPR-Cas9 into every cell. The tool works similarly to CRISPR-Cas9 but with a smaller RNA component, offering new starting point for more powerful and accessible gene editing tools.
A new type of RNA structure targeting tool has been developed to specifically recognise unusual four-strand RNA structures associated with diseases such as cancer and neurological disorders. The L-RNA aptamer-based rG4 targeting approach shows promise for developing new therapeutic tools.
Researchers have developed a new approach to studying RNA molecules using nanotechnology and cryo-electron microscopy (cryo-EM), enabling the analysis of RNA subunits with unprecedented resolution. This breakthrough has significant implications for fundamental research, drug development, and RNA therapeutics.
An international team of researchers has identified 5,500 new RNA virus species that represent all five known RNA virus phyla. The study suggests there are at least five new RNA virus phyla needed to capture them and highlights the importance of marine microbes in ocean adaptation to climate change.